First Mercantile Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-105,330
Closed -$2.19M – 876
2016
Q3
$2.19M Sell
105,330
-30,558
-22% -$758K 0.29% 79
2016
Q2
$3.65M Sell
135,888
-24,270
-15% -$666K 0.46% 47
2016
Q1
$4.34M Sell
160,158
-19,538
-11% -$523K 0.53% 38
2015
Q4
$5.22M Sell
179,696
-14,758
-8% -$408K 0.54% 33
2015
Q3
$5.27M Sell
194,454
-9,910
-5% -$281K 0.53% 26
2015
Q2
$5.59M Sell
204,364
-7,800
-4% -$219K 0.48% 33
2015
Q1
$5.66M Sell
212,164
-10,898
-5% -$251K 0.47% 36
2014
Q4
$4.72M Buy
223,062
+18,190
+9% +$406K 0.39% 58
2014
Q3
$4.88M Sell
204,872
-38,770
-16% -$892K 0.4% 54
2014
Q2
$5.63M Sell
243,642
-7,788
-3% -$172K 0.45% 39
2014
Q1
$5.74M Buy
251,430
+52,730
+27% +$1.12M 0.42% 41
2013
Q4
$3.67M Buy
198,700
+9,650
+5% +$168K 0.29% 74
2013
Q3
$3.2M Buy
189,050
+21,550
+13% +$362K 0.26% 85
2013
Q2
$2.6M Buy
+167,500
New +$2.79M 0.22% 102

Other funds holding NVO

First Mercantile Trust's NVO Position: Q4 2016 in Review

First Mercantile Trust sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 105,330 shares — an estimated $2.19M sold.

First Mercantile Trust first reported a position in NVO in Q2 2013 and held it in 14 quarters. The position peaked at $5.74M in Q1 2014. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • First Mercantile Trust reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • First Mercantile Trust sold 105,330 Novo Nordisk shares in Q4 2016, an estimated $2.19M.
  • First Mercantile Trust first reported a position in Novo Nordisk in Q2 2013 and held it in 14 quarters.
  • First Mercantile Trust's Novo Nordisk position peaked at $5.74M in Q1 2014.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on First Mercantile Trust's 13F filing for Q4 2016, filed 10 Feb 2017.